ClearChoice partners with Planmeca to bring enhanced digital imaging capabilities

The Planmeca Viso G7 CBCT imaging unit will serve patients at more than 75 ClearChoice dental implant centres in the US

Planmeca, Henry Schein and ClearChoice have entered a partnership to further elevate patient experience with enhanced digital imaging technology.

The ClearChoice doctors decided to integrate the Planmeca Viso G7, a cone-beam computed topography (CBCT) imaging unit that Planmeca offers, into the ClearChoice network of more than 75 centres across the US.

The distribution and implementation of the full Planmeca suite to each ClearChoice Dental Implant Centre will be managed by Henry Schein Dental, the dental division of Henry Schein.

Each ClearChoice Dental Implant Centre focuses on the same mission: delivering patient-centric, best-in-class solutions and techniques that can improve the lives of those suffering from acute oral disease.

ClearChoice envisions the CBCT as the ‘hub’ of a digital treatment plan for a patient, with the ability to combine CBCT, intraoral and facial scans into a complete digital record that can then be utilised throughout the patient’s treatment process from initial exam to final restoration.

Dr Theresa Wang, the lead pilot prosthodontist, noted that the Planmeca Viso G7 features a large field of view with low radiation to the patient, artificial intelligence that reduces noise and scatter, as well as movement correction to provide more diagnostic images and enrich treatment plan presentations.

Dr Thomas Berry, vice-president of surgical support for the ClearChoice Management Services (CCMS), also favours the Planmeca system: “The Planmeca Viso G7 offers strikingly clear scans, modules for creating surgical guides, and significantly less radiation to the patient. The unit also has the ability to perform a 3D facial photo of the patient that overlays the CBCT image.”

“The combination of superior image quality, smooth workflow and ease of use made the Planmeca Viso G7 the perfect choice for ClearChoice,” stated Glen Kendrick, president of Planmeca USA. “Many of the innovative features of the Planmeca Viso G7 fit ClearChoice’s patient-centric approach, including Planmeca Ultra Low Dose imaging protocols and Planmeca CALM, a proprietary patient movement correction algorithm.

“Innovative technology coupled with our dedication to continuous and ongoing education of both clinicians and staff, Planmeca is ready to partner with ClearChoice to provide a high-quality and seamless experience for a complex dental procedure.”

The Planmeca integration includes the Planmeca Romexis software. Romexis allows for 3D visualisation, customised treatment planning and centralises 3D imaging along with the 2D intraoral images captured by the Planmeca ProSensor HD and Planmeca ProX intraoral x-rays, further streamlining ClearChoice’s workflow.